ThesisOur thesisNewspaperInvestorsEntrepreneurs
Valorous Circle
InvestorsEntrepreneurs
ENG
FRA
ENG

Tool boxes/ Investors

icon plus blue and orange valeureux

First-time entrants bonus

24/9/2024
Philippe NUSSBAUMER
General Partner

Soon

Sign up for the Newsletter to be notified.

Link below.

icon plus blue and orange valeureux

News

France Parkinson invests in SAPPIENS

11/3/2025
Find the press release.
More information on this news →

Brussels October 4, 2024

4/10/2024
We will be in Brussels to support CXS Therapeutics during its meetings with a foundation that works on rare diseases. Let's meet on the occasion of this trip.
More information on this news →

Paris Sept. 23

23/9/2024
One to One meeting with investors/LP - get in touch, we still have a few slots left
More information on this news →

Lium - levee

20/8/2024
The capital increase was completed in the middle of August. Welcome Thomas and Guilain, PR to follow.
More information on this news →
icon plus blue and orange valeureux

More items

JEIR - 50% tax reduction excluding tax niches

Maecenas euismod sapien eu arcu convallis, vitae vestibulum ipsum maximus. Sed auctor Augue id Tellus Lacinia, nec u
Read the article

150-0b-ter Reuse at the service of the real economy

150-0b-ter Reuse at the service of the real economy
Read the article

First-time entrants bonus

The interest in investing before others
Read the article

No taxes on income on capital gains

nvesting in a Venture Capital Company (SCR) can offer individuals attractive tax advantages, in particular the exemption from income tax on capital gains realized after holding for more than five years
Read the article

Investor toolkits

Soon a first investment tool
Read the article
Early DeepTech?InvestorsEntrepreneursAbout
The letter
Thank you for subscribing to the newsletter
Whoops! An error occurred during registration
Investing in good conscience at the right time.
Make an appointment

Valeureux is a management company registered with the AMF under the number EN-24000009

Legal informationConfidentiality policy